Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
545 studies found for:    Open Studies | "Leukemia, Myeloid, Acute"
Show Display Options
Rank Status Study
21 Not yet recruiting A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Other: Standard Leukemia Care;   Other: Palliative Care
22 Recruiting A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia, in Relapse;   Recurrent Adult Acute Myeloid Leukemia
Interventions: Drug: GO-203-2c;   Drug: GO-203-2c + Decitabine
23 Recruiting A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Intervention: Drug: AGS67E
24 Recruiting HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: idarubicin;   Biological: microtransplantation
25 Recruiting Protocol in Acute Myeloid Leukemia With FLT3-ITD
Condition: Acute Myeloid Leukemia
Interventions: Drug: Midostaurin;   Drug: Cytarabine;   Drug: Daunorubicin
26 Not yet recruiting Study of Crenolanib in Combination Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations
Condition: Acute Myeloid Leukemia
Interventions: Drug: chemotherapy (Mitoxantrone, Cytarabine);   Drug: Placebo;   Drug: Crenolanib;   Other: Allogeneic stem cell transplantation
27 Recruiting A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia
Condition: Relapsed/Refractory Acute Myeloid Leukemia
Interventions: Drug: nintedanib and AML induction;   Drug: AML induction (placebo)
28 Recruiting A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: SGN-CD123A
29 Recruiting Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Biological: PEG-BCT-100
30 Recruiting A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: ASP2215;   Drug: Idarubicin;   Drug: Cytarabine
31 Not yet recruiting A Study to Evaluate Escalating Doses of AGS62P1 Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Intervention: Drug: AGS62P1
32 Recruiting A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia.
Condition: Acute Myeloid Leukemia
Interventions: Drug: ASP2215;   Drug: Idarubicin;   Drug: Cytarabine
33 Recruiting A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Biological: PF-06747143;   Drug: Cytarabine;   Drug: Daunorubicin;   Drug: Azacitidine;   Drug: Decitabine
34 Recruiting An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Decitabine 20 mg/m^2;   Drug: Talacotuzumab 9 mg/kg
35 Recruiting Mismatched Donor Cells to Treat Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Biological: ATAC Therapy
36 Recruiting Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Procedure: microtransplantation;   Biological: HLA-mismatched donor peripheral stem cell infusion
37 Recruiting Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia;   Refractory Acute Myeloid Leukemia
Intervention: Drug: IMGN779
38 Not yet recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
Condition: Acute Myeloid Leukaemia
Interventions: Drug: Gemtuzumab ozogamicin;   Drug: Liposomal daunorubicin;   Drug: Mitoxantrone;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Busulfan;   Drug: Cyclophosphamide
39 Recruiting Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Condition: Acute Myeloid Leukemia
Interventions: Drug: Cytarabine consolidation;   Drug: Allogeneic transplant
40 Recruiting Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: SGI-110

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.